Clinical Trials Directory
We are doing this study to test a new intervention that is designed to help adolescents and young adults who have signs and symptoms of an eating disorder. This study is funded by a grant from the National Institute of Mental Health.
We are doing this study to understand more about biomarkers (a part of your body) and how they can be used to better diagnose infection. To learn more, please contact us at DukeMESSIStudy@Duke.edu or at 919-452-1605. Estamos haciendo este estudio para entender más sobre biomarcadores (que son parte de su cuerpo) y cómo pueden ser usados estos para diagnosticar infecciones de una mejor manera. Para mayor información, por favor contáctenos al correo DukeMESSIStudy@Duke.edu o al número 919-452-1605.
We are doing this study to learn more about the cause of cardiac (heart) disease or sudden unexplained death, which is something that can run in families. Some conditions that we are looking at are:
- Cardiomyopathies (a disease of the heart muscle that makes it harder for your heart to pump blood to the rest of your body) like hypertrophic cardiomyopathy, dilated cardiomyopathy, or arrhythmogenic right ventricular cardiomyopathy
- Arrhythmia syndromes (a problem with the rate or rhythm of the heartbeat, either too slow or too fast) like long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or short QT syndrome
- Sudden cardiac arrest or unexplained sudden death (heart stops suddenly), including sudden infant death syndrome (SIDS)
We are doing this study to learn more about how genetic variations in people can impact how well different antibody-based drugs work for people who get organ transplants.
If you and your family join this study, you will:
- Have a 2-3 hour visit in the clinic to meet with the study doctor
- Have blood drawn for a test called Exome sequencing
- Have a telephone discussion of test results when they are available (6-9 months after the blood is drawn)
- Have a 1 hour discussion of test results in the clinic after the telephone discussion
We are doing this study to learn from patients' experiences about managing gastroesophageal reflux (GERD) and other risks related to lung transplantation.
We are doing this study to find out if giving heated chemotherapy into the belly, a procedure known as heated intraperitoneal chemotherapy (HIPEC), can improve treatment results for patients with ovarian cancer.
We are doing this study to find out if an experimental drug combination of mirvetuximab (MIRV) plus bevacizumab (BEV) is more effective at managing platinum-sensitive ovarian and fallopian tube cancers in a maintenance setting than bevacizumab on its own.